Ke Xu
- Cancer Research top 1%
- MicroRNA in disease regulation 21
- Cancer-related molecular mechanisms research 14
- Cancer, Hypoxia, and Metabolism 9
- Molecular Biology top 5%
- Circular RNAs in diseases 11
- Oncology top 5%
- Cancer Cells and Metastasis 11
- Cytokine Signaling Pathways and Interactions 8
- Immunology top 5%
- Toxicology top 5%
-
- Nanoplatforms for cancer theranostics 8
-
- Osteoarthritis Treatment and Mechanisms 8
- Journals
- Advanced Materials (2 papers)Angewandte Chemie International Edition (1 paper)SHILAP Revista de lepidopterología (3 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Ke Xu
138 papers receiving 4.2k citations
Hit Papers
Peers
Comparison fields: 5 of 134
- Cancer Research 1.1k
- Molecular Biology 2.1k
- Oncology 792
- Immunology 444
- Toxicology 71
Countries citing papers authored by Ke Xu
This map shows the geographic impact of Ke Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ke Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ke Xu more than expected).
Fields of papers citing papers by Ke Xu
This network shows the impact of papers produced by Ke Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ke Xu. The network helps show where Ke Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ke Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 4 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 17 | |
| 5 | 2025 | 4 | |
| 6 | 2025 | 7 | |
| 7 | 2025 | 0 | |
| 8 | Dynamic GelMA/DNA Dual‐Network Hydrogels Promote Woven Bone Organoid Formation and Enhance Bone Regenerationbreakdown → | 2025 | 24 |
| 9 | 2024 | 22 | |
| 10 | Boosting cartilage repair with silk fibroin-DNA hydrogel-based cartilage organoid precursorbreakdown → | 2024 | 98 |
| 11 | 2024 | 9 | |
| 12 | A Factor‐Free Hydrogel with ROS Scavenging and Responsive Degradation for Enhanced Diabetic Bone Healingbreakdown → | 2024 | 69 |
| 13 | 2023 | 6 | |
| 14 | 2023 | 2 | |
| 15 | 2023 | 27 | |
| 16 | Exosome-based bone-targeting drug delivery alleviates impaired osteoblastic bone formation and bone loss in inflammatory bowel diseasesbreakdown → | 2023 | 129 |
| 17 | 2023 | 22 | |
| 18 | 2022 | 3 | |
| 19 | 2022 | 2 | |
| 20 | 2018 | 33 |
About Ke Xu
Ke Xu is a scholar working on Cancer Research, Toxicology and Oncology, having authored 145 papers that have together received 4.2k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (21 papers), Cancer-related molecular mechanisms research (14 papers), Cancer Cells and Metastasis (11 papers), Circular RNAs in diseases (11 papers), Cancer, Hypoxia, and Metabolism (9 papers), Nanoplatforms for cancer theranostics (8 papers), Cytokine Signaling Pathways and Interactions (8 papers) and Osteoarthritis Treatment and Mechanisms (8 papers). The work is most often cited by research in Cancer Research (1.1k citations), Molecular Biology (2.1k citations) and Oncology (792 citations). Ke Xu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Peihao Yin, Xin Liang, Lei Yu, Jiacan Su, Yanyan Qiu, Jianwen Liu, Zeting Yuan, Xiang Wu, Boning Liu and Yueping Zhan. Their work appears in journals such as Advanced Materials, Angewandte Chemie International Edition and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.